Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost

Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost

Source: 
BioSpace
snippet: 

Cigna subsidiary Evernorth Health Services announced on Thursday that it will offer a Humira (adalimumab) biosimilar with no out-of-pocket cost via its specialty pharmacy Accredo.